Wallkill BioPharma Inc. — Form D
Wallkill BioPharma Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-28. The offering totals $208K, of which $208K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-03-28
- Form: D
- Accession: 0001735845-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $208K
- Amount sold: $208K
- Investors: 6
- Date of first sale: 2017-10-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-308764
Issuer
- Name: Wallkill BioPharma Inc.
- CIK: 0001735845
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1013 CENTRE ROAD, WILMINGTON, DE, 19805
- Phone: (858) 900-1521
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| MARTIN BELL | Director | NEW YORK, NY |
| GERALD SWISS | Director | RANCHO SANTA FE, CA |
| MARTIN BELL | Executive Officer | NEW YORK, NY |
| GERALD SWISS | Executive Officer | RANCHO SANTA FE, CA |
More